JJOLA
06.01.2010, 03:13
Promethean for AIO Premium cellular health in China
Tue. January 5, 2010; Posted: 14:19 PM
Symbols: OPGXE, PRMN
Are you looking to increase your ETF knowledge?
See the PowerRating of OPGXE,PRMN now and learn how it rates on a 1-10 scale.The higher the PowerRating, the greater potential short-term gain based on historical data.
Jan 05, 2010 (Datamonitor Financial Deals Tracker via COMTEX) --
Optigenex, Inc. has singed a long term exclusive license agreement with Promethean Corporation, a developer of healthcare products and services, for the distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11(R) in China. Optigenex is a technology-based developer of proprietary anti-aging ingredients for various health-related industries, including wellness, beauty and dietary supplements. Both the partners are based in the US.
AC-11(R) is a patented, all-natural rain forest botanical extract manufactured by Optigenex that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors.
Under the new agreement, Promethean through its wholly-owned subsidiary, Ceres Living will market the 'AIO Premium Cellular Health(TM)' line of advanced dietary supplements, as well as specially formulated next generation topical skin care products with AC-11(R). The contract vests Promethean with exclusivity in the North American direct sales or network marketing distribution channel coinciding with the expiration of similar channel rights previously held by former licensee.
In addition to North American direct sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia.
Deal Type Partnership
Sub-Category Acquisition of Rights,Marketing,Sales,Distribution
Deal Status Announced: 2010-01-04
Deal Participants
Partner 1 (Company) Ceres Living, Inc.
Partner 2 (Company) Optigenex, Inc.
Partner 3 (Company) Promethean Corporation
http://www.tradingmarkets.com/news/stock-alert/opgxe,prmn/optigenex-signs-license-agreement-with-promethean-for-aio-premium-cellular-health-in-china-681648.html (http://www.tradingmarkets.com/news/stock-alert/opgxe,prmn/optigenex-signs-license-agreement-with-promethean-for-aio-premium-cellular-health-in-china-681648.html)
Tue. January 5, 2010; Posted: 14:19 PM
Symbols: OPGXE, PRMN
Are you looking to increase your ETF knowledge?
See the PowerRating of OPGXE,PRMN now and learn how it rates on a 1-10 scale.The higher the PowerRating, the greater potential short-term gain based on historical data.
Jan 05, 2010 (Datamonitor Financial Deals Tracker via COMTEX) --
Optigenex, Inc. has singed a long term exclusive license agreement with Promethean Corporation, a developer of healthcare products and services, for the distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11(R) in China. Optigenex is a technology-based developer of proprietary anti-aging ingredients for various health-related industries, including wellness, beauty and dietary supplements. Both the partners are based in the US.
AC-11(R) is a patented, all-natural rain forest botanical extract manufactured by Optigenex that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors.
Under the new agreement, Promethean through its wholly-owned subsidiary, Ceres Living will market the 'AIO Premium Cellular Health(TM)' line of advanced dietary supplements, as well as specially formulated next generation topical skin care products with AC-11(R). The contract vests Promethean with exclusivity in the North American direct sales or network marketing distribution channel coinciding with the expiration of similar channel rights previously held by former licensee.
In addition to North American direct sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia.
Deal Type Partnership
Sub-Category Acquisition of Rights,Marketing,Sales,Distribution
Deal Status Announced: 2010-01-04
Deal Participants
Partner 1 (Company) Ceres Living, Inc.
Partner 2 (Company) Optigenex, Inc.
Partner 3 (Company) Promethean Corporation
http://www.tradingmarkets.com/news/stock-alert/opgxe,prmn/optigenex-signs-license-agreement-with-promethean-for-aio-premium-cellular-health-in-china-681648.html (http://www.tradingmarkets.com/news/stock-alert/opgxe,prmn/optigenex-signs-license-agreement-with-promethean-for-aio-premium-cellular-health-in-china-681648.html)